Abstract
Up to now, most hydrogel-related studies have been devoted to the preparation of drug-containing macromolecular gels via the introduction of polymer matrices, together with the clarification of their assembly mechanisms and biomedical applications. In contrast, studies concerning the design of small-molecule gel systems remain relatively limited. As gel research progresses, drug small-molecule hydrogels have attracted growing interest for formulation development. This study investigated whether designing a small-molecule hydrogel could serve as an effective solubilization approach for sulindac (SUL)—a nonsteroidal anti-inflammatory drug clinically restricted by its poor aqueous solubility. Then, a SUL small-molecule hydrogel was prepared by straightforward mixing of SUL with biologically safe meglumine (MEG) in a minimal volume of deionized water, which exhibited a characteristic three-dimensional network structure and favorable viscoelastic properties. The characterization and simulation results indicated that the hydrogel formation was contingent upon the SUL-MEG miscibility, dissolution-aggregation equilibrium and intermolecular self-assembly. Consequently, the resulting SUL-MEG hydrogel exhibited 546 times higher solubility compared to the pure SUL. Meanwhile, the SUL-MEG hydrogel demonstrated superior release kinetics and supersaturation capacity, characterized by rapid attainment of peak concentrations and sustained supersaturated release. These enhanced performances were attributed to the high-energy state of the hydrogel itself and the molecular complexation between SUL and MEG. In conclusion, this study presents a feasible formulation strategy for overcoming the poor water solubility of insoluble drugs through the development of small-molecule hydrogel formulations.
Funding Information
  • National Natural Science Foundation of China (82404546)
  • Natural Science Foundation of Jiangsu Province (BK20240964)
  • China Postdoctoral Science Foundation (2023M740377)
  • China Postdoctoral Science Foundation (2024M752702)
  • Changzhou Xitaihu Foundation for Frontier Technology of Cell Therapy Project (2024-P-057)
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province (SJCX25_1691)
  • Changzhou Sci & Tech Program (CQ20230080)
  • Changzhou Sci & Tech Program (CQ20240110)
  • Natural Science Foundation project of Nanjing University of Chinese Medicine (XZR2024070)

This publication has 41 references indexed in Scilit: